Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications

This publication has 95 references indexed in Scilit:

• Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator-Activated Receptor-α Activators
  Hypertension, 2005
• Peroxisome Proliferator-Activated Receptor-Alpha and Atherosclerosis
  Cardiology in Review, 2005
• Inhibitory Activity of Clinical Thiazolidinedione Peroxisome Proliferator Activating Receptor-γ Ligands Toward Internal Mammary Artery, Radial Artery, and Saphenous Vein Smooth Muscle Cell Proliferation
  Circulation, 2003
• Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease
  Circulation, 2003
• PPARα Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation
  Hypertension, 2002
• 15-Deoxy-prostaglandin J2 inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPARγ
  Biochemical and Biophysical Research Communications, 2002
• Increased Expression of Peroxisome Proliferator-Activated Receptor-α and -γ in Blood Vessels of Spontaneously Hypertensive Rats
  Hypertension, 2001
• Expression of Peroxisome Proliferator-Activated Receptor α (PPARα) in Primary Cultures of Human Vascular Endothelial Cells
  Biochemical and Biophysical Research Communications, 1998
• Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
  Cell, 1994
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987